CYP2E1

(cytochrome P450, family 2, subfamily E, polypeptide 1)

 

  • Alias                                 (According to NCBI)

 

  • CPE1,
  •  CYP2E,
  • P450-J,
  • P450C2E
  • OTTHUMP00000046571;
  • cytochrome P450 2E1;
  • cytochrome P450, subfamily IIE (ethanol-inducible),
  • polypeptide 1;
  • flavoprotein-linked monooxygenase; microsomal monooxygenase;
  • putative cytochrome P450 2E1;
  •  xenobiotic monooxygenase

 

  • Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.
  • Location: 10q24.3-qter
  • Size: 11754 bp
  • exons: 9
  • DNA sequence (Human): NC_000010.9

  • CGH (8q22):  Losses (%) -10.1   Gain (%)  1.7  

  • Mutations and SNPs (According to HGMD and SNP)

 

 

  • m-RNA                       (According to NCBI and CGAP)

 

  • Size: 493 amino acids; 56849 Da
  • Catalytic activity: RH + reduced flavoprotein + O2 = ROH + oxidized flavoprotein + H2O.
  • Subcellular location: Endoplasmic reticulum membrane; Peripheral membrane protein. Microsome membrane; Peripheral membrane protein.

  • Protein domains

     

 

  • Pathway:

          Kegg  Arachidonic acid metabolism

          Kegg  Linoleic acid metabolism

          Kegg  Metabolism of xenobiotics by cytochrome P450

          Biocarta  Mechanism of actaminophen activity and toxicity

          Biocarta  Nuclear receptors in lipid metabolism and toxicity

                        

  • Protein interactions: CYP2E1

  • Clinical                            (According to OMIM, PubMed)